Video

Exploring Another Biomarker in Ovarian Cancer

Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.

Folate receptor alpha is proving to be a promising biomarker to determine who may benefit from treatment with mirvetuximab soravtansine, also called “mirv,” according to David O’Malley, M.D., professor in the Department of Obstetrics and Gynecology at The Ohio State University Comprehensive Cancer Center.

In the FORWARD II study, researchers looked at “mirv” plus Avastin (bevacizumab) in patients with platinum-resistant ovarian cancer. There were three groups, including low expressers of folate receptor alpha (25 to 50 percent of cells expressing it), medium expressers (50 to 75 percent) and high expressers (more that 75 percent). Since “mirv” is a folate receptor alpha-targeting antibody-drug conjugate, the medium- and high-expresser groups had better results when it came to both progression-free survival and overall response rates. Now, this will be an area of focus moving forward, according to O’Malley.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
Related Content